コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 )In-octreotide it was 78.2%; specificity was not available).
2 ents per person-year (n = 17, patient 1 data not available).
3 eption of families in which DNA analysis was not available).
4 rate estimation of AAA rupture risk is still not available.
5 and policy efforts where biological data are not available.
6 the blood pool; histologic confirmation was not available.
7 t opinion because rigorous clinical data are not available.
8 Drug data for treatment of depression were not available.
9 whole-slide scanning microscopy systems are not available.
10 n is viable when biomonitoring organisms are not available.
11 N sources in the residential catchments are not available.
12 restricted because fresh-frozen tissues are not available.
13 he gene expression profile of these cells is not available.
14 diagnosis, and a management plan if CT were not available.
15 CR is delayed, shows negative results, or is not available.
16 hen glucose and other fermentable sugars are not available.
17 gle individual when mates or pollinators are not available.
18 ure for conventional wastewater treatment is not available.
19 Effective chemotherapy is not available.
20 lly understood; specific anti-HPV agents are not available.
21 e to growth faltering in early childhood are not available.
22 uts because individual-participant data were not available.
23 h preventative or therapeutic strategies are not available.
24 ison group and longitudinal assessments were not available.
25 ere conducted at a time when ranibizumab was not available.
26 that prevent or alleviate this condition are not available.
27 ody test result if HCV RNA measurements were not available.
28 t the relevant information in avian brain is not available.
29 mains for which ready-made formal models are not available.
30 but data from randomized clinical trials are not available.
31 structural basis for their mode of action is not available.
32 ng in lieu of direct observations, which are not available.
33 unity level where laboratory confirmation is not available.
34 ired by international law, they commonly are not available.
35 e, especially when hybrid (123)I SPECT/CT is not available.
36 selection of ISs whenever matching SILs are not available.
37 a (SaB) animal models, but clinical data are not available.
38 nors if donation after circulatory death was not available.
39 uming lizard eggs when green turtle eggs are not available.
40 rumental evaluations of GERD after LRYGB are not available.
41 eliable animal model of such TMJ diseases is not available.
42 rural areas in China during this period are not available.
43 fic regulatory T cells in vivo are currently not available.
44 where relevant experimental measurements are not available.
45 ongestion, and site-selective information is not available.
46 lete profiles for which experimental data is not available.
47 ary analyses because patient-level data were not available.
48 g complexes for which crystal structures are not available.
49 h sickle cell disease, but accurate data are not available.
50 rrogate tumor biopsy when Rb tumor tissue is not available.
51 aths in children worldwide, and a vaccine is not available.
52 m hematopoietic stem cell transplantation is not available.
53 ratory-based analytical procedures are often not available.
54 ecise estimates of time required for MOC are not available.
55 t (small) airways disease and emphysema were not available.
56 xcept in cases in which this information was not available.
57 toxicants and carcinogens in wastewater are not available.
58 ses where individual level genotype data are not available.
59 ering cell-state regulators when markers are not available.
60 to model the entire query protein are often not available.
61 ful tool for ASE analysis when genotypes are not available.
62 000 cancers annually worldwide, a vaccine is not available.
63 tudies, for most of them this information is not available.
64 ave a contraindication to CTPA or if CTPA is not available.
65 s for which three-dimensional structures are not available.
66 a required to fully test the hypothesis were not available.
67 ly because appropriate structural models are not available.
68 ic respiratory pathogens when vaccination is not available.
69 mical animal model for Ebola transmission is not available.
70 nterest is essential and a knockout mouse is not available.
71 iable high-resolution crystal structures are not available.
72 mitigate the adverse effects of drought are not available.
73 resolution for observing these processes are not available.
74 cordings of all motor commands are typically not available.
75 known because high-resolution information is not available.
76 action for which ChIP-quality antibodies are not available.
77 mage polypeptides were protective mechanisms not available.
78 Data about cause of death were not available.
79 olors in complex food matrices are currently not available.
80 needed to validate these tools are typically not available.
81 pproaches, and clear treatment protocols are not available.
82 f vector control interventions is limited or not available.
83 priate for cases where a reference genome is not available.
84 ies) when high-quality local survey data are not available.
85 a working diagnosis of IPF if lung tissue is not available.
86 feine on objective measures of vigilance are not available.
87 tive data on the source of the infection are not available.
88 ive vaccines against norovirus infection are not available.
89 ial standards for goat genetic variants were not available.
90 vidual sequenced) when parental samples were not available.
91 hod of preparing reproducible quantities was not available.
92 g; however, outcomes by EVH device type were not available.
93 cine to prevent C. trachomatis infections is not available.
94 model parameter when empirical trip data is not available.
95 where blood pressure-lowering medicines were not available.
96 sed vaccines or suitable antiviral drugs are not available.
97 Not available.
98 Up to now, approved treatment options are not available.
99 d only for interventions for which RCTs were not available.
100 nvasive biomarkers for PSC, CCA, and HCC are not available.
101 e decision making when immediate feedback is not available.
102 ecially where electronic medical records are not available.
103 ortical pathways when PER-POR interaction is not available.
104 s included in the risk prediction models was not available.
105 ta for peak expiratory flow variability were not available.
106 especially when high-quality antibodies are not available.
107 one country endomysial antibodies (EMA) were not available.
108 oorly understood and targeted treatments are not available.
109 tion calling method when normal controls are not available.
110 for metazoa that undergo DNA elimination are not available.
111 data with direct-acting antiviral agents are not available.
112 or semi-automated variant interpretation are not available.
113 of studies for which the required data were not available.
114 res external allele frequency data which may not available.
115 ress, especially if the protein structure is not available.
116 easy scheme for their in vitro synthesis is not available.
117 lters endogenous protein levels is currently not available.
118 sity or period of time (season) is currently not available.
119 a good alternative when higher resolution is not available.
120 ZER Septal Occluder in clinical practice are not available.
121 ody test result if HCV RNA measurements were not available.
122 ted for CJD, in part because an easy test is not available.
123 re likely when beds were available than when not available (269/275 [34%] vs 6/275 [15%], p=0.010).
124 -matched donors, but when a matched donor is not available, a haploidentical or mismatched unrelated
126 ods for use when cell-type specific DMRs are not available, allowing scientists to estimate putative
127 n improved cure rates, but an HCV vaccine is not available and is urgently needed to control the glob
128 the chemo-resistivity of the cancer cells is not available and it currently takes weeks to months to
129 Commercial inhibitors for HtrA proteases are not available and physiologic HtrA inhibitors are unknow
130 k for patients undergoing TAVR are currently not available and should be derived from a population th
131 in recent years, but prospective studies are not available and the complication profile is poorly und
132 spectively; chronic daily headache 5% (3-7), not available, and 12% (8-19), respectively; musculoskel
134 where original individual-level records are not available, and employs a covariance shrinkage algori
135 inding sites where structural information is not available, and is invaluable for the development of
137 but their potent and specific inhibitors are not available, and strategies for inhibitor development
138 models to predict risk for complications are not available, and the effect of treatment on risk is un
139 uidelines for appropriate workforce size are not available, and the next steps needed to address the
140 In the reference scenario, self-testing is not available, and the rate of first-time and repeat PHT
141 because selective high affinity ligands are not available, and the threshold for heat activation is
145 ody test results and response to therapy are not available at disease onset, we based the initial dia
149 ase of the 2009 H1N1 pandemic, a vaccine was not available before the first pandemic wave hit and the
152 al data containing structural restraints are not available, but one still wants to obtain knowledge a
155 be extended to produce other SOA components not available commercially to improve quantification of
159 rinciples of thermodynamics and kinetics are not available, despite the critical role that such preci
160 ion on the internal OC exposure in humans is not available, due to the lack of appropriate biomarkers
166 spite recent progress, experimental data are not available for all relevant pesticide-plant combinati
168 ely understood and structural information is not available for any of the reaction intermediates.
169 proteins of interest; (ii) the ones that are not available for any protein of interest, but exist in
173 es, invasive mechanical ventilation is often not available for children at risk of death from respira
176 noscale MOFs, rapid and flexible methods are not available for continuous, one-pot synthesis and post
185 size and cost, large-scale synchrotrons are not available for more routine applications in small and
186 of choice; however, these genetic tools are not available for most organisms and alternative labelin
190 heavily on uniquely mapping reads, which are not available for numerous isoforms that lack regions of
191 e that information on thromboprophylaxis was not available for patients who had plaster cast immobili
194 Furthermore, analytical results are often not available for several days, which slows the process
201 the rate of future cognitive decline that is not available from a dichotomous positive/negative categ
202 recise information about local conformations not available from average-resolution X-ray structures a
203 ffects on child development, and evidence is not available from countries of low or middle income.
205 arch data can provide a breadth of knowledge not available from individual sources and can provide co
209 mical insights at the single organelle level not available from organelle population level studies.
210 the potential to provide biological insights not available from studies restricted to European popula
212 itionally each modality provides information not available from the other providing both a molecular
215 recall and response bias, symptom assessment not available in 24% of patients, and missing data for s
216 , emerging anti-angina treatments (which are not available in all parts of the world), and experiment
220 eeting abstracts, "gray" literature, studies not available in English, and studies with non-original
224 istinguish clinically, and rapid testing was not available in many Ebola Treatment Units (ETUs), guid
226 to political and regulatory barriers, it is not available in many settings around the world, which l
234 increased cocaine seeking when the drug was not available in rats trained to discriminate its presen
240 D and the resulting reducing equivalents are not available in the outermost few nanometers of clay su
242 ormation for this study (information that is not available in the publically available SEER dataset).
246 where electrophysiology subspecialty care is not available leads to outcomes that are noninferior to
247 n overall survival was 15.8 (95% CI, 13.0 to not available) months with aldoxorubicin and 14.3 (95% C
248 D for whom an HLA-identical family donor was not available; most were not responding well to ERT.
258 -59 days) with suspected sepsis is sometimes not available or feasible in countries with high neonata
259 dictions where diacetylmorphine is currently not available or for patients in whom it is contraindica
261 ul when expertise in esophageal manometry is not available or not tolerated and when esophageal manom
262 50 ms if shortest preexcited RR interval was not available) or inducible atrioventricular re-entrant
264 ng physicians indicated that if NaF PET were not available, other advanced imaging (body CT, MR imagi
265 arbitrary numbers of hybrid layers which are not available otherwise, because epitaxial strain is avo
266 nfirm that when measured gas-phase SVOCs are not available, "predicted-total" SVOCs should be used to
267 back control of cardiac electrical activity, not available previously with pharmacological and electr
269 ly; joint pain 14% (11-18), 42% (26-60), and not available, respectively; and widespread pain 14% (9-
270 ested for LGV, or if confirmatory testing is not available, should be treated empirically with a reco
272 ovel and advanced scientific techniques were not available, such as genomics techniques for pinpointi
273 for which extensive genotyping resources are not available, such as wild progenitors of crops, orphan
274 r the 118 countries for which 2012 data were not available, the 2012 cesarean delivery rate was imput
275 t candidates when recombination map data are not available, the [Formula: see text] and [Formula: see
277 l equations describing a physical process is not available, the new approach can significantly accele
278 ontrol at the liquid/solid interface that is not available through conventional CVD synthesis at the
279 the possibility that complete continua were not available through our comprehensive search of the pu
280 lifetime-risk data for implant revision are not available to aid patient decision making, which is a
281 chromatographic/mass spectrometric data were not available to compare with the data used in the analy
282 resource on the miRNA regulome is currently not available to facilitate the exploration and understa
283 ality performance and outcome indicators are not available to guide patient choice, these policies co
284 suitable questionnaire in German language is not available to monitor the progression and evaluate th
285 he high volume of sequence homologs that are not available to most of the non-humongous protein targe
286 s is a result of the rich d electron physics not available to nanocomposites based on sp bonded graph
289 generally applicable methodologies are still not available to the computational and medicinal chemist
290 nzymes or deletion of competing pathways are not available to the metabolic engineer; instead, fatty
292 source in vitro, we demonstrate that heme is not available to V. cholerae in the infant mouse intesti
294 ication runs even when a native structure is not available, visualizing the contact coverage and simi
295 cond-generation direct-acting antivirals are not available, W28 of BOC-based triple therapy may be re
296 uctures of the human LRRK2 kinase domain are not available, we used novel high-throughput assays that
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。